Not yet recruiting
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC
NCT07432568
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
Not specified